首页> 美国卫生研究院文献>Journal for Immunotherapy of Cancer >P67. Targeted natural killer (NK) cell based adoptive immunotherapy for the treatment of patients with non-small cell lung cancer (NSCLC) after radiochemotherapy (RCT) – clinical application of NK cells activated by heat shock protein 70 (Hsp70)

【2h】

P67. Targeted natural killer (NK) cell based adoptive immunotherapy for the treatment of patients with non-small cell lung cancer (NSCLC) after radiochemotherapy (RCT) – clinical application of NK cells activated by heat shock protein 70 (Hsp70)

机译：P67。基于靶向自然杀伤（NK）细胞的过继免疫疗法用于治疗放化疗（RCT）后的非小细胞肺癌（NSCLC）患者–热激蛋白70（Hsp70）激活的NK细胞的临床应用

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

期刊名称 Journal for Immunotherapy of Cancer
作者
HM Specht; J Pelzel; H Hautmann; RM Huber; B Schossow; M Molls; G Multhoff;
展开▼
作者单位

展开▼
年(卷),期 2014(2),Suppl 2
年度 2014
页码 P41
总页数 1
原文格式 PDF
正文语种
中图分类肿瘤学;
关键词
入库时间 2022-08-17 11:52:12

相似文献

外文文献
中文文献
专利

1. P67. Targeted natural killer (NK) cell based adoptive immunotherapy for the treatment of patients with non-small cell lung cancer (NSCLC) after radiochemotherapy (RCT) – clinical application of NK cells activated by heat shock protein 70 (Hsp70) [J] . HM Specht, J Pelzel, H Hautmann, Journal for ImmunoTherapy of Cancer . 2014,第S2期

机译：P67。基于靶向自然杀伤（NK）细胞的过继免疫疗法，用于治疗放化疗（RCT）后的非小细胞肺癌（NSCLC）患者–热休克蛋白70（Hsp70）激活的NK细胞的临床应用
2. Heat Shock Protein 70 (Hsp70) Peptide Activated Natural Killer (NK) Cells for the Treatment of Patients with Non-Small Cell Lung Cancer (NSCLC) after Radiochemotherapy (RCTx) – From Preclinical Studies to a Clinical Phase II Trial [J] . Hanno M. Specht, Norbert Ahrens, Christiane Blankenstein, Frontiers in Immunology . 2015,第12期

机译：热休克蛋白70（Hsp70）肽激活的自然杀伤（NK）细胞用于放射化学治疗（RCTx）后的非小细胞肺癌（NSCLC）患者的治疗-从临床前研究到临床II期试验
3. Heat Shock Protein 70 (Hsp70) Peptide Activated Natural Killer (NK) Cells for the Treatment of Patients with Non-Small Cell Lung Cancer (NSCLC) after Radiochemotherapy (RCTx) – From Preclinical Studies to a Clinical Phase II Trial [J] . Hanno M. Specht, Norbert Ahrens, Christiane Blankenstein, Frontiers in Immunology . 2015,第4期

机译：热休克蛋白70（Hsp70）肽激活的自然杀伤（NK）细胞用于放射化学治疗（RCTx）后的非小细胞肺癌（NSCLC）患者的治疗-从临床前研究到临床II期试验
4. The clinical efficacy of transfusion of cytokine-induced killer cells combined with chemotherapy and XiaoJi decoction in patients with stage IIIB/IV non-small cell lung cancer [C] . Liuning Li, Jiaying Liu, Xiaoshu Chai, IEEE International Conference on Bioinformatics and Biomedicine . 2014

机译：细胞因子诱导的杀伤细胞输注结合化学疗法和消积汤治疗IIIB / IV期非小细胞肺癌的临床疗效
5. CD16xCD33 bispecific killer cell engager (BiKE) activates natural killer (NK) cells from myelodysplastic syndrome (MDS) patients against primary MDS and myeloidderived suppressor cell (MDSC) CD33-positive targets. [D] . Gleason, Michelle K. 2014

机译：CD16xCD33双特异性杀伤细胞接合剂（BiKE）激活来自骨髓增生异常综合征（MDS）患者的自然杀伤（NK）细胞，以抵抗原发性MDS和髓样抑制细胞（MDSC）CD33阳性靶标。
6. Heat Shock Protein 70 (Hsp70) Peptide Activated Natural Killer (NK) Cells for the Treatment of Patients with Non-Small Cell Lung Cancer (NSCLC) after Radiochemotherapy (RCTx) – From Preclinical Studies to a Clinical Phase II Trial [O] . Hanno M. Specht, Norbert Ahrens, Christiane Blankenstein, 2015

机译：热休克蛋白70（Hsp70）肽激活的自然杀伤（NK）细胞用于放射化学治疗（RCTx）后的非小细胞肺癌（NSCLC）患者的治疗-从临床前研究到临床II期试验
7. P67. Targeted natural killer (NK) cell based adoptive immunotherapy for the treatment of patients with non-small cell lung cancer (NSCLC) after radiochemotherapy (RCT) – clinical application of NK cells activated by heat shock protein 70 (Hsp70) [O] . HM Specht, J Pelzel, H Hautmann, 2014

机译：P67。基于靶向自然杀伤（NK）细胞的过继免疫疗法，用于治疗放化疗（RCT）后的非小细胞肺癌（NSCLC）患者–热激蛋白70（Hsp70）激活的NK细胞的临床应用

P67. Targeted natural killer (NK) cell based adoptive immunotherapy for the treatment of patients with non-small cell lung cancer (NSCLC) after radiochemotherapy (RCT) – clinical application of NK cells activated by heat shock protein 70 (Hsp70)

著录项

相似文献

相关主题

期刊订阅